Table 3.
Patients (n = 70) | |
---|---|
Number of patients with HCC recurrence, n (%) | 21 (30) |
Site of recurrence, n (%) | |
Intrahepatic recurrence | 16 (76.2) |
Extrahepatic recurrence | 3 (14.3) |
Both intra- and extrahepatic recurrence | 2 (9.5) |
Time until recurrence, n | |
<1 year | 19 |
≥1 year | 2 |
Major treatment for tumor recurrence, n | |
Repeat hepatectomy | 3 |
Radiofrequency ablation | 4 |
Radiotherapy | 7 |
Second-line systemic therapy | 2 |
Systemic therapy + TACE | 2 |
None | 3 |
HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization.